Pontificia Universidad Católica de Chile
Santiago, Santiago Metropolitan, 8320000, Chile
NCT Number: NCT04526236
Increasingly, elderly patients undergo anesthesia and surgery. Methadone is a great opioid for perioperative pain management, however, to date there are no pharmacokinetic or pharmacodynamic studies that asses a methadone dose adjustment in the elderly patient. The present study is aimed to characterize the pharmacokinetic and pharmacodynamic age-related changes of methadone in the adult population and further to design reference dosing protocols for intraoperative methadone use according to patient age.
Looking for future studies?
Notify Me18 year–105 year
All sexes
Interventional
Phase 4
Santiago, Santiago Metropolitan, 8320000, Chile
The subjects will be recruited from adult patients who undergo elective laparoscopic abdominal surgery at UC Christus Clinical Hospital (Santiago, de Chile). Patients will be randomly divided into four groups according to the dose of intravenous methadone to be administered during anaesthetic induction.
BIS-guided and standard general anaesthesia will be administered with routine monitoring. Methadone will be administered once the patient is intubated and has hemodynamic stability. The only opioids that patients will receive will be remifentanil and methadone.
Upon admission to the Post-anesthesia care unit, the patient is given a Patient-Control Analgesia pump for intravenous administration of morphine. Clinic evaluations will be carried out periodically and blood samples for measurement of plasma methadone will be taken at different times. Samples will be analyzed using high-performance liquid chromatography spectrofluorometric method. The data obtained will be collected in a form within the REDCAP application, to subsequently generate an encrypted database. Groups will be compared regarding pain score, drugs used, opioid consumption, side effects, time of recovery, and patient satisfaction.
One, two and three-compartment linear models will be used to fit the plasma methadone concentration data over time. Models are parameterized in terms of elimination clearance, compartment distribution clearance, central volume and peripheral volume of distribution, as appropriate. The use of rescue morphine in the Post-anesthesia care unit will be used as a measure to relate the methadone dose (mg/kg) with the analgesic efficacy using an EMAX model. The data will be modelled using NONMEM VII. A proportional term will be used for variability between subjects. Additive and proportional terms will be used to characterize the unknown residual variability.
Sample size calculations were estimated using a simulation-based approach and previous work with a similar methodology. To achieve an adequate representation of all age groups 60 patients will be required, distributed among 20 patients between 18 and 40 years, 20 patients between 41 and 65 years, and 20 patients> 65 years.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Perioperative use of placebo for pain management and remifentanil during the surgery.
Other names: Methadone 0, Methadone 1 0,05 mg/kg, Methadone 2 0,1 mg/kg, Methadone 3 0,2 mg/kg
Time frame: From the first dose up to 24 hours.
Five venous blood samples will be taken from each patient for methadone plasmatic level analysis. Patients will be randomly divided into two groups with different sample collection times. Group 1 at 0.05, 0.75, 1.5, 6, 18 hours post drug administration and Group 2 at 0.25, 1, 3, 12 and 24 hours.
Time frame: Every 5 min. Since entering operating room up to end of anesthesia and leaving to recovery room. In average 2 hrs. Then, from the entrance to the recovery room every 30 minutes up to 180 minutes.
Non invasive systolic and diastolic blood pressure monitoring (mmHg).
Time frame: Every 5 min. Since entering operating room up to end of anesthesia and leaving to recovery room. In average 2 hrs. Then, from the entrance to the recovery room every 30 minutes up to 180 minutes.
Heart rate (bpm)
Time frame: Every 5 min. Since entering operating room up to end of anesthesia and leaving to recovery room. In average 2 hrs. Then, from the entrance to the recovery room every 30 minutes up to 180 minutes.
% oximetry saturation
Time frame: Every 5 min. Since entering operating room up to end of anesthesia and leaving to recovery room. In average 2 hrs.
Depth of anesthesia will be recorded with BIS monitor. From 60 - 40
Time frame: Every 30 minutes. Since entering the recovery room up to 180 mins.
bpm
Time frame: Every 30 minutes. Since entering the recovery room up to 180 mins.
Numeric Pain rating scale in rest and movement, from 0 (no pain) to 10 (maximum pain).
Time frame: Every 30 minutes. Since entering the recovery room up to 180 mins.
Presence of nausea or vomiting in the recovery room.
Time frame: Every 30 minutes. Since entering the recovery room up to 180 mins.
Ramsay scale (1-6)
Time frame: Every 30 minutes. Since entering the recovery room up to 180 mins.
Presence of respiratory depression in the recovery room. (Respiratory rate less than 8 bpm requiring oxygen therapy).
Time frame: Since the admission to the recovery room up to 2 hours.
Name and total doses, including Morphine PCA.
Time frame: Since the admission to the recovery room up to 2 hours.
Time to first flatus, fist bowel movement and stool. Presence of abdominal bloating.
Time frame: Once, before the anesthetic induction in the operating toom.
Body fat (kilograms) by body impedance analysis.
Time frame: Since the admission to the recovery room up to 2 hours.
10-point scale: very unsatisfied to very satisfied.
Time frame: Once, before the anesthetic induction in the operating toom.
Lean mass (kilograms) by body impedance analysis.
Time frame: Once, before the anesthetic induction in the operating toom.
Total water (kilograms) by body impedance analysis.
Pontificia Universidad Catolica de Chile
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04749628
Arthritis, Joint Diseases
New York, United States
View Trial DetailsNCT07164664
Acute Pain, Neurologic Manifestations
Samsun, Turkey (Türkiye)
View Trial DetailsNCT07253610
Body Weight, Laparoscopic Sleeve Gastrectomy (LSG)
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT03726268
Neurologic Manifestations, Opioid Use
Durham, North Carolina, United States
View Trial Details